$IBB Company News S&P, Nasdaq within striking distance

New Post Public Reply Private Reply Replies (0) Message Board

Oct 29, 2014 at 10:53 AM

$IBB Company News

S&P, Nasdaq within striking distance of 50-day average 11:22 a.m. Oct. 24, 2014 - Michael Ashbaugh
Broadly-based snapback strengthens bull case 11:10 a.m. Oct. 22, 2014 - Michael Ashbaugh
U.S. stocks jump; Nasdaq enjoys best day in 21 months 4:38 p.m. Oct. 21, 2014 - Anora Mahmudova
U.S. benchmarks hesitate at major resistance 10:26 a.m. Oct. 20, 2014 - Michael Ashbaugh
Charting a failed retest of the 200-day average 11:16 a.m. Oct. 15, 2014 - Michael Ashbaugh
Tekmira CEO says being a biotech is like being in ‘shark-infested water’ 8:03 a.m. Oct. 8, 2014 - Wallace Witkowski
Charting the October technical breakdown 11:06 a.m. Oct. 2, 2014 - Michael Ashbaugh
Charting the S&P 500’s precarious posture 10:44 a.m. Sept. 25, 2014 - Michael Ashbaugh
Nasdaq balks at the September peak 10:40 a.m. Sept. 22, 2014 - Michael Ashbaugh
U.S. stocks end lower; tech and small-caps lead losses 4:09 p.m. Sept. 15, 2014 - Anora Mahmudova
Stock-picking gains traction as volatility looms 6:01 a.m. Sept. 7, 2014 - Wallace Witkowski
S&P clears the 2,000 mark, reaches uncharted territory 11:49 a.m. Aug. 26, 2014 - Michael Ashbaugh
S&P clears the 2,000 mark, reaches uncharted territory 11:35 a.m. Aug. 26, 2014 - Michael Ashbaugh
This one stock sector can withstand all the ‘bubble’ talk 6:01 a.m. Aug. 21, 2014 - Jeff Reeves
S&P 500 retests the breakdown point 11:17 a.m. Aug. 14, 2014 - Michael Ashbaugh
U.S. stocks push higher; biotechs rally 4:06 p.m. Aug. 13, 2014 - Anora Mahmudova
Dow, S&P 500 inch up, while Nasdaq, Russell 2000 slip: stock market live blog recap 3:34 p.m. July 28, 2014 - blogs.marketwatch.com
Momentum plays stabilize: Biotech, social-media stocks rally in the past week 5:52 p.m. July 25, 2014 - blogs.marketwatch.com
Stocks bounce back Friday, end with gains for the week: live blog recap 3:21 p.m. July 18, 2014 - blogs.marketwatch.com
Another bear market for froth stocks? 3:03 p.m. July 17, 2014 - John Nyaradi

Don't Fight The Fed? 12:28 p.m. Oct. 27, 2014 - Seeking Alpha
New Highs May Not Happen Till Mid-November 9:01 p.m. Oct. 26, 2014 - InvestorPlace.com
Biotechs are running circles around internet stocks 9:44 a.m. Oct. 26, 2014 - Seeking Alpha
Best And Worst ETFs Of The Week Amid Biotech Breakout 3:41 p.m. Oct. 24, 2014 - Benzinga.com
Biotech Breakout: Technical Analysis And Major News 8:49 a.m. Oct. 24, 2014 - Seeking Alpha
Are Blue-Chip Stocks Past Their Prime or Still Worth Owning? 4:15 p.m. Oct. 23, 2014 - TheStreet.com
Amgen And Regeneron Reach All-Time Highs Together: Updates On Both Biotech Stalwarts 8:46 a.m. Oct. 23, 2014 - Seeking Alpha
Trading Biopharmaceutical Stocks After Significant One-Day Declines Revisited 8:14 a.m. Oct. 22, 2014 - Seeking Alpha
Nasdaq Stages Turnaround; Here’s What Needs to Happen Next 9:59 p.m. Oct. 21, 2014 - InvestorPlace.com
Put This Fund at the Top of Your Long-Term Buy List 8:14 p.m. Oct. 20, 2014 - InvestorPlace.com
Sientra on deck for IPO 1:48 p.m. Oct. 20, 2014 - Seeking Alpha
Make Sure Your Portfolio Is Working For You 6:30 a.m. Oct. 20, 2014 - InvestorPlace.com
5 Best Biotech Stocks to Buy Now 6:02 a.m. Oct. 20, 2014 - InvestorPlace.com
Dead Cat Bounce or the Real Deal? 9:48 p.m. Oct. 19, 2014 - InvestorPlace.com
Evaluating The Best Biotech ETF Options 2:03 a.m. Oct. 19, 2014 - Seeking Alpha
Proteon Therapeutics on deck for IPO 1:02 p.m. Oct. 17, 2014 - Seeking Alpha
Endostim on deck for IPO 12:28 p.m. Oct. 17, 2014 - Seeking Alpha
Feds examine what went wrong at Texas hospital where two nurses infected with Ebola 8:46 a.m. Oct. 16, 2014 - Seeking Alpha
Investors Being Presented With an Unusual Buying Opportunity 9:43 p.m. Oct. 13, 2014 - InvestorPlace.com
Amgen spin-out on deck for IPO 11:29 a.m. Oct. 10, 2014 - Seeking Alpha

Premier Biomedical Advances Technology via Partnerships 10:29 a.m. May 9, 2014 - ACCESSWIRE
OxySure's Improving Financials & Operational Milestones Paint a Bullish Picture 9:01 a.m. March 10, 2014 - ACCESSWIRE
Regulus Announces Addition to NASDAQ Biotechnology Index 9:00 a.m. Dec. 23, 2013 - PR Newswire
Epizyme, Inc. to Be Added to NASDAQ Biotechnology Index (NBI) and NASDAQ Global Select Market 9:00 a.m. Dec. 20, 2013 - PR Newswire
KYTHERA Biopharmaceuticals Announces Addition to the NASDAQ Biotechnology Index 6:51 p.m. Dec. 19, 2013 - GlobeNewswire
Verastem Announces Addition to the NASDAQ Biotechnology Index 8:00 a.m. Dec. 19, 2013 - BusinessWire
Horizon Pharma to Be Added to NASDAQ Biotechnology Index 8:30 a.m. Dec. 17, 2013 - Marketwire
Chimerix Added to NASDAQ Biotechnology Index (NBI) 8:00 a.m. Dec. 17, 2013 - GlobeNewswire
Annual Changes to the NASDAQ Biotechnology Index 9:05 a.m. Dec. 16, 2013 - GlobeNewswire
Galectin Stands Out in 2013 with Liver Fibrosis Drug 12:06 p.m. Oct. 14, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARRY, GNVC, IDIX and NVAX 9:02 a.m. Sept. 16, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARIA, ARNA, EXEL and OREX 9:05 a.m. Sept. 11, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on CYTX, GALT, IMMU and OXBT 8:52 a.m. Sept. 11, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ACHN, BLRX, DSCO and ONCY 8:51 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ACAD, CUR, INO and PIP 8:41 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on DNDN, HALO, MNKD and PDLI 8:30 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on GILD, ITMN, MDVN and PBYI 9:01 a.m. Sept. 6, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ALXN, AMGN, CBST and CLDX 8:50 a.m. Sept. 6, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on BIIB, CYTK, ISIS and SRPT 8:40 a.m. Sept. 6, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ANAC, RPRX, THLD and THRX 8:52 a.m. July 17, 2013 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PenFed Credit Union's Soaring Loan Originations in Q3 2026

Staggering Growth in Loan Originations Ever wake up to an unexpected windfall? That's the kind of headline PenFed Credit Union is writing with its $8.8 billion in year-to-date loan originations by the end of September 2026. Up 22% year-over-year, folks. Those numbers don't just happen by accident. That's hitting the nail on the head in the credit union world. Mortgage and...

AstroRad Vest Makes Spaceflight History at Smithsonian

Space Gear Finds a New Home In a move that brings a piece of the cosmos down to Earth, the AstroRad radiation protection vest, used by astronauts aboard the International Space Station (ISS), has landed a spot in the Smithsonian's National Air and Space Museum. It's not just some random hunk of tech; this vest represents a milestone in the annals of space gear — a...

Cooper's Stock Takes a Beating: What's Behind It?

A Shock to the System: Cooper's Rough Patch Not every day you see a stock take a body slam like this! Cooper Companies (NASDAQ: COO) got walloped after revealing some unsavory truths about its Q3 2026 performance. The market didn't just flinch—it reeled. On September 10, 2026, COO shares dove a steep $9.31—around a 14.6% free fall—whacking off over $1.7 billion in...

Green Methanol: A $20.11B Market by 2032 Excites

The Green Methanol Boom Folks, the money's about to get greener—greener methanol, that is. We’re talking about a market that’s set to explode from a humble $3.46 billion in 2026 to a jaw-dropping $20.11 billion by 2032. With a hefty CAGR of 34.1%, it seems like investors might want to buckle up for a bullish ride in this eco-friendly venture. Why Green Methanol?...

Del Monte Faces Class Action Over Major Data Breach

Data Breach Fallout Looms Over Del Monte Here's the scoop on Del Monte Foods facing what looks like a data breach debacle of epic proportions. Ransomware has hit the fan, and now folks are scrambling as Edelson Lechtzin LLP gears up to lay down some serious class action heat. From Cyber Shadows to Court Considerations This storm brewed on February 7, 2026. Del Monte’s...

Cytrellis Boosts Aesthetics Training With Miami Partnership

Cytrellis Partners with University of Miami The announcement from Cytrellis Biosystems is drawing some attention. The company's jumped into a new partnership with the University of Miami School of Nursing and Health Studies, looking to jazz up their Aesthetic Medicine Certificate Program. The kicker here is the introduction of Cytrellis' ellacor® system, a fancy bit of...

BioArctic's Moves: Lecanemab Data and Leadership Insights

BioArctic's Power Play: A Two-Pronged Update Ever feel like biotechnology is just a series of chess moves? BioArctic's recent maneuvers in the life sciences game certainly hint at that. First, they've got data brewing on lecanemab—this ain't small beans, folks, not with Alzheimer's disease in the crosshairs. Then there's their Nomination Committee. It’s like shaking...

SCI Faces Investigation After Earnings Downgrade

SCI's Rough Ride: Investors Brace for Impact There's nothing like waking up to find the stock you were banking on took a nosedive while you were dreaming of dividends. Service Corporation International (NYSE: SCI) sure gave shareholders more of a nightmare than a dream, slashing its earnings forecast for 2026 and watching its stock crumble by about 11.6% on October 29....

Intestinal Worms: New Science and Old Challenges

Intestinal Worms: A Modern Twist on an Old Tale Just when you thought you'd heard it all, here comes the notion that intestinal worms might actually be good for us. The stuff of cringe-worthy junior high biology classes is now strutting its stuff in F1000Research. Sounds odd? Maybe, but there's a half-century of science behind it. Old Foes with New Friends These...

Gastops and Bell: A New Era in Aerospace Collaboration

Gastops and Bell Seal a Forward-Looking Deal Who would've thought Gastops and Bell, two juggernauts in their respective fields, would link arms to drive the aerospace game forward in Canada? That's right, a Memorandum of Understanding (MOU) was inked between these titans at the 2026 Canadian Aerospace Summit, paving the way for collaboration on future programs. This isn't...